Collectively, these mechanisms integrate lipid uptake, synthesis and storage under the control of the HIF-2α–CD36 axis, representing a central metabolic vulnerability and a promising therapeutic target in ccRCC (26). The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.